Treatment for EBV (Infectious Mononucleosis)
For otherwise healthy adolescents and young adults with infectious mononucleosis, treatment is entirely supportive—antivirals are not recommended and have no proven benefit.
Primary Management Approach
The cornerstone of treatment is symptomatic care only 1, 2:
- Activity modification: Reduce activity and rest as tolerated based on the patient's energy level—do not enforce strict bed rest 1, 2
- Hydration: Ensure adequate fluid intake
- Symptom relief: Use analgesics and antipyretics for fever and pain
- Sports restriction: Mandatory withdrawal from contact or collision sports for at least 8 weeks after symptom onset or while splenomegaly persists to prevent splenic rupture (occurs in 0.1-0.5% of cases and is potentially fatal) 1
What NOT to Use
Antiviral Medications
Antivirals (acyclovir, valacyclovir, ganciclovir) are NOT recommended for routine treatment 2, 3. While these agents show some in vitro activity against replicating EBV, they are ineffective against latently infected B cells since these cells do not express the viral thymidine kinase enzyme needed for drug activation 4. The evidence shows no benefit in uncomplicated infectious mononucleosis 3.
Corticosteroids
Corticosteroids are NOT recommended for routine use 2. They should be reserved exclusively for specific life-threatening complications:
- Severe upper airway obstruction or respiratory compromise
- Severe pharyngeal edema threatening the airway
- Possibly immune-mediated severe anemia or thrombocytopenia 3
Antihistamines
Not recommended for routine treatment 2.
Common Pitfalls to Avoid
Inappropriate antibiotic use: A striking 82.6% of hospitalized IM patients receive antibiotics in the prehospital period 5, most commonly amoxicillin/clavulanate, which is unnecessary and contributes to antimicrobial resistance. The clinical similarity between IM and streptococcal pharyngitis drives this overuse. Do not prescribe antibiotics unless bacterial superinfection is documented.
Premature return to sports: Emphasize the 8-week restriction from contact sports—splenic rupture is the most feared complication 1.
Expected Clinical Course
- Most patients have an uneventful, self-limited recovery 1
- Fatigue, myalgias, and increased sleep needs may persist for several months after acute infection resolves 2
- IM is a risk factor for chronic fatigue syndrome 1
When to Consider Antiviral Therapy
The only scenario where antivirals might be considered is in severe, life-threatening manifestations (CNS involvement, severe hepatitis, respiratory distress) as an adjunct to corticosteroids 6. However, even in these cases, the evidence derives only from case reports and series, making conclusions about efficacy highly debatable 6.
Note: The guidelines provided 4 address EBV management in post-transplant patients with immunosuppression—this is a completely different clinical context and does not apply to healthy adolescents with typical infectious mononucleosis.